ERBB2 and neoplasm: In this phase II trial, the IHC staining was performed with either the 4D5 or CB11 antibody, and the HER2 tumor expression was scored as 0, 1+, 2+, or 3+ using standardized scoring criteria, as shown in Table 1 (17).